205 related articles for article (PubMed ID: 21232035)
1. Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy.
Meng LQ; Tang JW; Wang Y; Zhao JR; Shang MY; Zhang M; Liu SY; Qu L; Cai SQ; Li XM
Br J Pharmacol; 2011 Apr; 162(8):1805-18. PubMed ID: 21232035
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV synergizes with ferulic acid to suppress hepatic stellate cells activation in vitro.
Dong H; Guo H; Liang Y; Wang X; Niu Y
Free Radic Res; 2017 Feb; 51(2):167-178. PubMed ID: 28147890
[TBL] [Abstract][Full Text] [Related]
4. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats.
Zhao XM; Zhang J; Liang YN; Niu YC
Dig Dis Sci; 2020 Oct; 65(10):2925-2936. PubMed ID: 31900718
[TBL] [Abstract][Full Text] [Related]
6. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.
Rhyu DY; Yang Y; Ha H; Lee GT; Song JS; Uh ST; Lee HB
J Am Soc Nephrol; 2005 Mar; 16(3):667-75. PubMed ID: 15677311
[TBL] [Abstract][Full Text] [Related]
7. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
8. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.
Yuan Q; Wang R; Peng Y; Fu X; Wang W; Wang L; Zhang F; Peng Z; Ning W; Hu G; Wang Z; Tao L
Am J Nephrol; 2011; 34(2):181-94. PubMed ID: 21791914
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV ameliorates renal fibrosis via the inhibition of mitogen-activated protein kinases and antiapoptosis in vivo and in vitro.
Xu W; Shao X; Tian L; Gu L; Zhang M; Wang Q; Wu B; Wang L; Yao J; Xu X; Mou S; Ni Z
J Pharmacol Exp Ther; 2014 Sep; 350(3):552-62. PubMed ID: 24951279
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction.
Vieira JM; Mantovani E; Rodrigues LT; Dellê H; Noronha IL; Fujihara CK; Zatz R
Nephrol Dial Transplant; 2005 Aug; 20(8):1582-91. PubMed ID: 15855201
[TBL] [Abstract][Full Text] [Related]
11. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction.
Miyajima A; Chen J; Lawrence C; Ledbetter S; Soslow RA; Stern J; Jha S; Pigato J; Lemer ML; Poppas DP; Vaughan ED; Felsen D
Kidney Int; 2000 Dec; 58(6):2301-13. PubMed ID: 11115064
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling.
Zhang L; Xu X; Yang R; Chen J; Wang S; Yang J; Xiang X; He Z; Zhao Y; Dong Z; Zhang D
Drug Des Devel Ther; 2015; 9():2139-48. PubMed ID: 25931810
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.
Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466
[TBL] [Abstract][Full Text] [Related]
14. Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy.
Liu N; Tolbert E; Ponnusamy M; Yan H; Zhuang S
J Pharmacol Exp Ther; 2011 Sep; 338(3):758-66. PubMed ID: 21622732
[TBL] [Abstract][Full Text] [Related]
15. [Investigate the effects of compound radix notoginseng on renal interstitial fibrosis and kidney-targeting treatment].
Xie XS; Zuo C; Zhang ZY; Liu HC; Feng SG; Zhang CL; Yuan W; Fan JM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):28-33. PubMed ID: 22455126
[TBL] [Abstract][Full Text] [Related]
16. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
[TBL] [Abstract][Full Text] [Related]
17. Glycolysis inhibitors suppress renal interstitial fibrosis via divergent effects on fibroblasts and tubular cells.
Wei Q; Su J; Dong G; Zhang M; Huo Y; Dong Z
Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1162-F1172. PubMed ID: 30969803
[TBL] [Abstract][Full Text] [Related]
18. Lefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
Zhang L; Zhang J; Xu C; Zhou X; Wang W; Zheng R; Hu W; Wu P
Drug Des Devel Ther; 2015; 9():4669-78. PubMed ID: 26316705
[TBL] [Abstract][Full Text] [Related]
19. Preventive effects and mechanisms of rhein on renal interstitial fibrosis in obstructive nephropathy.
He D; Lee L; Yang J; Wang X
Biol Pharm Bull; 2011; 34(8):1219-26. PubMed ID: 21804209
[TBL] [Abstract][Full Text] [Related]
20. Melatonin ameliorates renal fibroblast-myofibroblast transdifferentiation and renal fibrosis through miR-21-5p regulation.
Li N; Wang Z; Gao F; Lei Y; Li Z
J Cell Mol Med; 2020 May; 24(10):5615-5628. PubMed ID: 32243691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
